Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data-Reference-Cited by-同舟云学术

Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data

Published:2022-02-25 Issue:2 Volume:40 Page:320-328
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Rademacher Jan-Gerd¹,Glaubitz Stefanie²,Zechel Sabrina³,Oettler Manuela¹,Tampe Björn¹,Schmidt Jens⁴,Korsten Peter⁵

Affiliation:

1. Department of Nephrology and Rheumatology, University Medical Centre Göttingen, Germany.

2. Department of Neurology, University Medical Centre Göttingen, Germany.

3. Institute of Neuropathology, University Medical Centre Göttingen, Germany.

4. Department of Neurology, University Medical Centre Göttingen; Department of Neurology and Pain Treatment, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, and Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.

5. Department of Nephrology and Rheumatology, University Medical Center Göttingen, Germany. peter.korsten@med.uni-goettingen.de

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand;Seminars in Arthritis and Rheumatism;2024-10

2. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments;Journal of Autoimmunity;2024-09

3. Myopathies induites par les statines : une entité rare ?;Revue du Rhumatisme;2024-06

4. Management of immune‐mediated necrotizing myopathy;Muscle & Nerve;2024-05-27

5. Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab – a case-based review;ARP Rheumatology;2024-05-18